SCHEMBL6692790

SCHEMBL6692790

Cc1[nH]c2ccc(CCN(C3CCCCC3)S(C)(=O)=O)cc2c1C(=O)OC(C)c1cc(F)c(F)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.36
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
ALDH1A1 P00352 3/20 0.34
LMNA P02545 3/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 1/20 0.33
GAA P10253 1/20 0.32
MAPK1 P28482 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315018 0.90 KMT2A (0.36) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL6685583 0.83 MEN1 (0.41) HTTAPOBEC3AAPOBEC3GMEN1KMT2A
SCHEMBL6321113 0.82 GAA (0.40) ALDH1A1LMNAMAPTSMN1; SMN2GAA
SCHEMBL6318228 0.80 LMNA (0.34) LMNASMN1; SMN2GAA
SCHEMBL6318232 0.80 LMNA (0.40) KMT2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL6692830 0.79 LMNA (0.35) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL6321009 0.79 LMNA (0.40) KMT2AALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL6317350 0.78 ALDH1A1 (0.41) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL6315810 0.78 KMT2A (0.37) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL6323871 0.78 KMT2A (0.37) MEN1KMT2AALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR Millennium Pharmaceuticals, Inc. (US) 2004-01-07 EP disclosed
WO-2002072549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-09-19 WO disclosed